Entity

Time filter

Source Type

Antwerp, Belgium

The University of Antwerp is one of the major Belgian universities located in the city of Antwerp. The name is abbreviated as UAntwerp, but sometimes as UA.As of 2014, the University of Antwerp ranks as 170th globally according to Times Higher Education, 205th according to QS World University Rankings and between the 301 and 400th place according to the Academic Ranking of World Universities. Wikipedia.


Patent
University of Antwerp and Shakturana Cv | Date: 2013-03-18

The present invention relates to the field of HIV-1 infections, and in particular provides novel compounds containing triazine rings and suitable spacers. The compounds according to this invention are very suitable for the prevention and/or treatment of HIV-1 infection and in particular show improved activity against NNRTI-resistant viruses of HIV-1.


Patent
University of Antwerp, Plantijn College and Novosanis Nv | Date: 2013-07-26

A device for capturing a predetermined volume of a predefined portion (e.g. first void) of a liquid flow, comprises an inlet, an outlet, and a guide with an element displaceable in a first position for capturing the first liquid portion in a reservoir, and in a second position for blocking access to the reservoir, and for passing the liquid to the outlet. The displaceable element moves in transverse direction to the liquid flow, and has lifting means. The element may be substantially flat, or tubular with an elliptical cross section. A kit of parts and a method of assembly are also claimed.


Patent
Catholic University of Leuven and University of Antwerp | Date: 2014-07-30

A method of treating and/or preventing Dravet Syndrome in a patient such as a patient previously diagnosed with Dravet Syndrome, by administering an effective dose of fenfluramine or its pharmaceutically acceptable salt to that patient. Dravet Syndrome patients are typically children under the age of 18 and are treated at a preferred dose of less than about 0.5 to about 0.01 mg/kg/day.


Patent
Catholic University of Leuven and University of Antwerp | Date: 2014-07-30

A method of treating and/or preventing Dravet Syndrome in a patient such as a patient previously diagnosed with Dravet Syndrome, by administering an effective dose of fenfluramine or its pharmaceutically acceptable salt to that patient. Dravet Syndrome patients are typically children under the age of 18 and are treated at a preferred dose of less than about 0.5 to about 0.01 mg/kg/day.


Patent
Catholic University of Leuven and University of Antwerp | Date: 2014-07-30

A method of treating and/or preventing Dravet Syndrome in a patient such as a patient previously diagnosed with Dravet Syndrome, by administering an effective dose of fenfluramine or its pharmaceutically acceptable salt to that patient. Dravet Syndrome patients are typically children under the age of 18 and are treated at a preferred dose of less than about 0.5 to about 0.01 mg/kg/day.

Discover hidden collaborations